Two investors team up for CordenPharma buyout following mRNA vaccine success
In March, CordenPharma was listed among the pharma giants picked by the German government as recipients of more than $3 billion to ensure that the country had enough production capacity to make Covid-19 vaccines for future outbreaks. Investors at Astorg and ICIG seemed to have liked what they saw and announced Monday that the private equity firms have teamed up to acquire the CDMO.
With the acquisition, Astorg and ICIG will get a rapidly growing company thanks to its involvement in the mRNA vaccine game. Corden has also positioned itself as a key player in the world of peptides and high-potency compounds for oncology. It picked up Vifor Pharma’s drug manufacturing wing in December 2021, landing operations in Fribourg and Ettingen, Switzerland, and Lisbon, Portugal.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.